Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23

Trial Status

Completed1
Recruiting2
Terminated2
Other1

Role Distribution

Principal Investigator5
Other Roles1
PI Rate83%

Activity Timeline

Clinical Trials (6)

NCT06524973Not ApplicableRecruiting
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers
Metastatic Pancreatic Adenocarcinoma
PrincipalinvestigatorStart date: 2024-10-07
NCT05227326Phase 1Recruiting
AOH1996 for the Treatment of Refractory Solid Tumors
LeiomyosarcomasNon-Small Cell Lung CancerOsteosarcoma+4 more
PrincipalinvestigatorStart date: 2022-09-08
NCT04929392Phase 2Active Not Recruiting
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8+16 more
PrincipalinvestigatorStart date: 2022-01-25
NCT01191684Phase 1Completed
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer
Recurrent Colon CancerRecurrent Gastric CancerRecurrent Pancreatic Cancer+9 more
PrincipalinvestigatorStart date: 2011-12-22
NCT00544908Phase 2Terminated
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
Pancreatic Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungColorectal CancerOvary Cancer+2 more
Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungOvary CancerCancer of Pancreas+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+1 more

Worked with same sponsors:

City of Hope Medical Center
Similarity Score3%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of PancreasColorectal CancerCarcinoma, Non-Small-Cell Lung+1 more
Similarity Score3%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Recurrent Colon CancerStage IV Colon CancerStage IV Pancreatic Cancer
Similarity Score2%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Ovary CancerCarcinoma, Non-Small-Cell LungCancer of Pancreas
Similarity Score2%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of PancreasColorectal CancerEsophageal Squamous Cell Carcinoma
Similarity Score2%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungStage III Pancreatic CancerStage IV Pancreatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)United States Department of Defense
Similarity Score2%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Ovary CancerCancer of PancreasColorectal Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Tim F Greten, M.D.

National Cancer Institute (NCI)

Related
22 trials

Shared therapeutic areas:

Colorectal CancerCancer of PancreasOvary Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT06524973Not ApplicablePrincipalInvestigator

Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers

Metastatic Pancreatic Adenocarcinoma
Recruiting
NCT05227326Phase 1PrincipalInvestigator

AOH1996 for the Treatment of Refractory Solid Tumors

LeiomyosarcomasNon-Small Cell Lung CancerOsteosarcoma+4 more
Recruiting
NCT04929392Phase 2PrincipalInvestigator

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8+16 more
Active Not Recruiting
NCT01191684Phase 1PrincipalInvestigator

Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer

Recurrent Colon CancerRecurrent Gastric CancerRecurrent Pancreatic Cancer+9 more
Completed
NCT00538291Phase 2StudyChair

Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

Colorectal Cancer
Terminated
NCT00544908Phase 2PrincipalInvestigator

Dasatinib in Treating Patients With Stage IV Pancreatic Cancer

Pancreatic Cancer
Terminated

All 6 trials loaded